ArticleFrontiers in immunology2026

Low-level hepatitis B surface antigen by ECLIA stratifies early relapse risk in patients with interferon-based HBV functional cure.

Xiangyong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.